Innoviva, Inc.INVANASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
5Y CAGR+1.4%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

5Y CAGR
+1.4%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 qtr
Consecutive growthAccelerating
PeriodValue
Q4 202516.99%
Q3 20253.78%
Q2 2025-3.92%
Q1 2025-12.24%
Q4 202419.48%
Q3 2024-5.41%
Q2 2024-8.83%
Q1 202415.52%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 20220.00%
Q3 2022-100.00%
Q2 202281.48%
Q1 2022108.54%
Q4 20218.85%
Q3 2021-32.36%
Q2 2021-29.37%
Q1 202158.78%
Q4 202015.86%
Q3 202025.35%
Q2 20201.29%
Q1 20209.91%
Q4 2019-53.00%
Q3 201914.15%
Q2 201944.18%
Q1 201914.29%
Q4 2018-34.36%
Q3 2018-8.89%
Q2 2018-48.17%
Q1 201849.58%
Q4 2017-2.27%
Q3 2017-4.20%
Q2 2017-7.33%
Q1 201716.98%
Q4 20169.81%
Q3 2016-17.99%
Q2 2016-0.43%
Q1 201629.68%